Skip to main content.

Studies Currently Enrolling

KU School of Medicine-Wichita Center for Clinical Research is looking for volunteers to participate in research studies.

Studies may include:

  • time/travel reimbursement
  • medication
  • clinical evaluations
  • medical tests
  • physical exams


View details of current studies:

Pediatrics

  • Constipation (ages 6-17) - A Phase 3, multicenter, randomized, double-blind, placebo-controlled, parallel-group, safety and efficacy study of linaclotide administered orally to children, Ages 6 to 17 years, with IBS with constipation.
  • Research database - You are being asked to participate in our research participant database. The purpose of this database is to collect personal health information to determine if you qualify for any current and/or future research studies.

Adults

  • Agitation in Alzheimer’s A 9 to 26-week study, on treatment of agitation associated with dementia of the Alzheimer's type. Participants must be 65-90 years of age with a caregiver who spends 16+ hours a week with the participant. Compensation is provided for time and travel, and the study drug is provided free of charge.
  • ACTIV-6 COVID-19 treatment – A research study to see if certain FDA-approved medications can help people with mild to moderate COVID-19 feel better faster and stay out of the hospital. Participants must be at least 30 years old, have tested positive for COVID-19 within 10 days and have at least two of a specific set of symptoms. Participants will receive by mail either a placebo or a study medication, answer short, daily online surveys for 14-28 days and complete a follow-up survey after 90 days. A gift card of up to $100 will be awarded upon completion of the study. Learn more from the study flyer.
  • COPD - A multi-center, randomized, 36-month, parallelgroup, non-inferiority, Phase 3 study to compare the effectiveness of 500 mcg QD oralternate regimen of roflumilast (Daliresp) therapy versus 250 mg QD, 500 mg QD three times per week, or alternate regimen of azithromycin therapy to prevent COPD exacerbations.
  • Dementia - Study is 18 months long, with six months of active intervention, six months of maintenance and a six-month follow-up. Participants must be ages 55 or older with mild to moderate dementia. Participants must have a caregiver. Participants will be randomized to one of two exercise programs. Learn more from the study flyer.
  • Depression - A 13-week study for adults with depression. Participants must be 18 to 65 years of age, and be on a stable dose of an antidepressant for ≥ 6 weeks in the current major depressive episode. The study includes eight office visits and two telemedicine visits and pays $75-50 per visit.
  • Research database - You are being asked to participate in our research participant database. The purpose of this database is to collect personal health information to determine if you qualify for any current and/or future research studies.
  • Personality disorders - Genetic profile and ancestry information for participants 18 years and older, with personality disorders.
  • Treatment Resistant Depression - A 9- to 16-week study on treatment of Esketamine for adults with treatment resistant depression. Participants must be 18 to 65 years of age, have been diagnosed with major depressive disorder (MDD) for at least 8 weeks and have failed 2-5 trials of antidepressants in the current major depressive episode. The study includes medication.

Ready to participate or have questions?

Contact us at 316-293-1833 or complete the online interest form:

Complete the Clinical Trials Interest Form
KU School of Medicine-Wichita

1010 North Kansas
Wichita, KS 67214-3199
316-293-2635